Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-12-06

Clinical Trial Update: Sunitinib Malate Related Fatigue in Patients With Metastatic Kidney Cancer [NA]

View source ↗

Summary

Clinical trial update on sunitinib-related fatigue in metastatic/advanced renal cell cancer was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sunitinib malate (sunitinib malate)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Fatigue, Recurrent Renal Cell Cancer | NA | Status: TERMINATED | Results posted: 2018-12-06